trimetazidine has been researched along with Autoimmune Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jovanović, A; Liu, XY; Tan, W; Tang, SG; Wang, HH; Wang, SP | 1 |
| Deng, SB; He, L; She, Q; Xia, S; Xiang, YL; Xiao, J; Xiu, Y | 1 |
| Pogátsa, G | 1 |
1 review(s) available for trimetazidine and Autoimmune Diabetes
| Article | Year |
|---|---|
[New concepts in the therapy of diabetic cardiopathies].
Topics: Adenosine Triphosphate; Cardiomyopathies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Trimetazidine | 1997 |
2 other study(ies) available for trimetazidine and Autoimmune Diabetes
| Article | Year |
|---|---|
Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2/TRPC3-induced oxidative stress.
Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Disease Models, Animal; Male; Molecular Targeted Therapy; NADPH Oxidase 2; Oxidative Stress; Rats, Wistar; Trimetazidine; TRPC Cation Channels | 2019 |
Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fatty Acids; Glucose; Myocytes, Cardiac; Potassium Channels; Rats; Rats, Sprague-Dawley; Streptozocin; Trimetazidine; Vasodilator Agents | 2012 |